background image

FTSE at 9,000: UK Equities Find a New Lease of Life

Equities 3 minutes to read
Neil Wilson
Neil Wilson

Investor Content Strategist

Note: This is marketing material. This article is not investment advice, capital is at risk.

FTSE at 9,000: UK Equities Find a New Lease of Life

Key Points

  • FTSE 100 breaks 9,000 for the first time
  • UK offers highest dividend yield and relative valuation discount
  • Defence, Basic Resources, Financials among index leaders in 2025

The UK market achieved a new milestone today as the FTSE 100 broke the 9,000 barrier for the first time. We’ve heard a lot of doom and gloom about UK equities and the health of the stock market, but it underlines why I’ve been upbeat about the UK market this year.

Here’s a few thoughts on what’s going on.

Diversification away from US leadership has been a factor as US economic policy uncertainty rose this year and tariffs appeared – the FTSE has been a safe harbour in a stormy market for a number of reasons. The interesting thing is that we’ve hit 9,000 as sterling has seen a big rally against the dollar this year – magnifying the relative performance between UK and US equities.

The UK securing an early trade deal with Washington has helped remove some overhang relative to other markets, particularly Europe. The UK could see investment due to the need to divert exports to the US via the UK. In a world of 20-30% tariffs, a 10% rate makes the UK a winner and provides advantages to UK exporters.

Relative valuations have started to matter again due to macroeconomic conditions and higher rates with UK trading on forward earnings multiple at 13x vs US at 22x starts to look appealing. The UK has derated significantly since 2016 and is trading at its lowest in relative terms in 30 years. Low beta and defensive and positioning is light – a good place to head if markets turn.

The FTSE’s dividend yield is also the highest in developed markets. Investors may be tempted increasingly towards dividend strategies going forward – we are hearing this is happening. I wrote about the merits of dividend-focused stocks as the cornerstone of an equity portfolio recently.

Combine the yield + valuation discount and defensive characteristics and you get an appealing place to position in during a tough macro backdrop where picking winners is maybe harder than it has been until now when it was TINATA – there is no alternative to America.

Index makeup matters – defensives, longer-term plays, companies that are not being disrupted by tech (eg miners and defence, drinks, tobacco). Old fashioned stuff like free cash flow and balance sheets have mattered once more.

A flight to safety has supported Precious Metals – Fresnillo is the best performer this year, rising 155% YTD, due to record high gold prices and silver hitting a 14-year high. When the world can’t stop spending, rea assets like commodities are appealing – the FTSE’s basic resources focus has been a tailwind.

Major realignment of defence priorities has boosted stocks like Rolls-Royce and Babcock. RR is up 75% YTD and Babcock has risen 120%, while another major defence name, BAE Systems, is 65% higher for 2025.

Higher rates and inflation supports certain sectors like banks and financials, with Lloyds up more than 40% this year and Prudential rising 47%.
The FTSE’s global footprint has helped. Africa-focused Endeavour Mining and Airtel Africa have both rallied sharply this year.

But there are concerns about the position the UK economy is in. This is a double-edged sword for UK investors though.

The international focus of the FTSE 100 – with about two-thirds of earnings derived from abroad – offers some sanctuary on that front too for now, but the UK’s precarious fiscal position and lacklustre economic growth suggests trouble ahead for some more domestically-focused sectors.

The question will be whether domestic weakness is enough to pull down the index – I think that is unlikely to be a major problem, but we should note that pressure on gilts could cloud some judgments about the UK market.

On the other hand, political pressure on the Labour government, a looming fiscal crisis and lower Bank of England rates ought to push sterling lower and provide some further tailwinds for the blue chips.

And on tariffs, names like AstraZeneca and GSK are not out the woods yet as Trump has threatened 200% tariffs on drugs.

Overall, I’d say the FTSE has attraction from a value, income and defensive perspective given the volatility we have seen and changed macro backdrop and assumptions about US exceptionalism. a) it's offering some relative shelter with defensive names, b) benefitting from flow dynamics as investors look beyond the US, c) is enticing value-focused investors with relatively low multiples when growth is at a premium, d) offers a good dividend income yield and e) may be picking up a little juice from the government’s capital investment plans for defence/energy/houses. 10,000 here we come?

 

 

Quarterly Outlook

01 /

  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992